Stem Cell Apoptosis and Signal Transmission
Regeneration and proliferation of stem cells are controlled in part, by the induction of apoptosis. The number of stem cells is therefore a balance between those lost in differentiation / apoptosis and those gained by proliferation. Stem cell apoptosis, or programmed cell death, is a critical process for maintaining tissue homeostasis and preventing uncontrolled cell growth. Apoptosis in stem cells is regulated by various intracellular and extracellular signaling pathways that respond to environmental stressors, DNA damage, or developmental cues. Key signaling molecules like caspases, Bcl-2 family proteins, and death receptors mediate the apoptotic cascade, ensuring controlled elimination of damaged or unneeded cells. Signal transmission for apoptosis involves pathways such as the intrinsic (mitochondrial) pathway, which responds to internal stress, and the extrinsic (death receptor) pathway, triggered by external signals like ligands binding to receptors on the cell surface. Proper regulation of apoptosis in stem cells is crucial to prevent diseases such as cancer or degenerative disorders, as dysregulation can lead to either excessive cell death or survival of damaged, potentially malignant cells. the release of stem cell factor prevents apoptosis following spinal cord injury, possibly in an effort to promote tissue repair. Dysregulation of apoptosis in stem cells is believed to be associated with cancer pathologies, where apoptotic resistance causes uncontrolled growth .Controlling apoptosis is also important in stem cell transplant studies, where prevention may increase the survival of grafted cells during further treatment. Binding the full potential to treat stem cells will require a full specification of signal transduction cascades for proliferation, isolation, and apoptosis.
Related Conference of Stem Cell Apoptosis and Signal Transmission
19th International Conference on Human Genomics and Genomic Medicine
22nd World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
17th International Conference on Human Genetics and Genetic Diseases
Stem Cell Apoptosis and Signal Transmission Conference Speakers
Recommended Sessions
- Bio Banking Stem cell
- Bone Marrow Transplantation
- CAR-T Cell Therapy: Current Status and Future Directions
- Cell and Genetic Therapy
- Cellular Reprogramming and Induced Pluripotent Stem Cells
- Clinical Methods
- Dental Stem Cells
- ell-Based Therapies for Neurological Disorders
- Neurodegenerative Disease
- Research and Development of Stem Cell & Regenerative Drugs
- Stem Cell Animal Applications
- Stem Cell Apoptosis and Signal Transmission
- Stem Cell Embryology
- Stem Cell in Drug Discovery
- Theories of Aging in Stem Biology
- Tissue Engineering
- Tissue Engineering and 3d Cell Culture
- Translational Research in Stem Cell Assessments
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Advanced Imaging and Single-Cell Technologies - cellscience-cs-2027 (UK)
- Animal Genetics - Genome 2027 (Germany)
- Artificial Intelligence in Cell and Molecular Research - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - Genome 2027 (Germany)
- Biomarkers and Microarrays - Genome 2027 (Germany)
- Biotechnology and Molecular Therapeutics - cellscience-cs-2027 (UK)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Cell Biology and Molecular Oncology - cellscience-cs-2027 (UK)
- Cancer Genomics - Genome 2027 (Germany)
- Cell Biology and Cellular Mechanisms - cellscience-cs-2027 (UK)
- Cellular Metabolism and Metabolic Biology - cellscience-cs-2027 (UK)
- Cellular signaling and Signal Transduction - cellscience-cs-2027 (UK)
- Clinical genomics - Genome 2027 (Germany)
- Comparative Genomics - Genome 2027 (Germany)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Emerging Technologies and Future Directions in Cell Science - cellscience-cs-2027 (UK)
- Epigenomics and Epigenetics - Genome 2027 (Germany)
- Functional Genomics - Genome 2027 (Germany)
- Gene Editing and Genetic Engineering - Genome 2027 (Germany)
- Genetic Disorder - Genome 2027 (Germany)
- Genetics, Genomics and Genome Biology - cellscience-cs-2027 (UK)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Genomic Instability - Genome 2027 (Germany)
- Genomic Medicine - Genome 2027 (Germany)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Immunology and Cellular Immunity - cellscience-cs-2027 (UK)
- Microbial Genomics - Genome 2027 (Germany)
- Molecular Biology and Gene Regulation - cellscience-cs-2027 (UK)
- Molecular Diagnostics and Biomarkers - cellscience-cs-2027 (UK)
- Molecular Medicine and Translational Research - cellscience-cs-2027 (UK)
- Molecular Microbiology and Host–Pathogen Interactions - cellscience-cs-2027 (UK)
- Next generation sequencing - Genome 2027 (Germany)
- Nutrigenomics - Genome 2027 (Germany)
- Personalized and Regenerative Medicine - Genome 2027 (Germany)
- Pharmacogenomics - Genome 2027 (Germany)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Plant Genomics and Molecular Pharming - Genome 2027 (Germany)
- Stem Cell Biology and Regenerative Medicine - cellscience-cs-2027 (UK)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Structural Genomics - Genome 2027 (Germany)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)
- Trends in Genomics and Pharmacogenomics - Genome 2027 (Germany)
